APA (7th ed.) Citation

Kraya, A. A., Maxwell, K. N., Eiva, M. A., Wubbenhorst, B., Pluta, J., Feldman, M., . . . Nathanson, K. L. (2022). PTEN Loss and BRCA1 Promoter Hypermethylation Negatively Predict for Immunogenicity in BRCA-Deficient Ovarian Cancer. JCO Precision Oncology, 6, 1. https://doi.org/10.1200/PO.21.00159

Chicago Style (17th ed.) Citation

Kraya, Adam A., et al. "PTEN Loss and BRCA1 Promoter Hypermethylation Negatively Predict for Immunogenicity in BRCA-Deficient Ovarian Cancer." JCO Precision Oncology 6 (2022): 1. https://doi.org/10.1200/PO.21.00159.

MLA (9th ed.) Citation

Kraya, Adam A., et al. "PTEN Loss and BRCA1 Promoter Hypermethylation Negatively Predict for Immunogenicity in BRCA-Deficient Ovarian Cancer." JCO Precision Oncology, vol. 6, 2022, p. 1, https://doi.org/10.1200/PO.21.00159.